Skip Navigation Links
Centers for Disease Control and Prevention
CDC Home Search Health Topics A-Z




DISSS Home | Contact Us
 Health and Human Services Logo



Animated FirstGov Logo - Click to enter FirstGov


Lymphogranuloma Venereum (Chlamydia trachomatis)

Contents
Home - National Notifiable Diseases Surveillance System
Overview
Introduction
List of Nationally Notifiable Diseases
Alphabetical List of Case Definitions
Definition of Terms
Related Links
References
  Site Search


1997 Case Definition

Clinical description

Infection with L1, L2, or L3 serovars of Chlamydia trachomatis may result in a disease characterized by genital lesions, suppurative regional lymphadenopathy, or hemorrhagic proctitis. The infection is usually sexually transmitted.

Laboratory criteria for diagnosis

  • Isolation of C. trachomatis, serotype L1, L2, or L3, from clinical specimen, or
  • Demonstration by immunofluorescence of inclusion bodies  in leukocytes of an inguinal lymph node (bubo) aspirate, or
  • Positive microimmunofluorescent serologic test for a lymphogranuloma venereum strain of C. trachomatis (in a clinically compatible case)

Case classification

Probable: a clinically compatible case with one or more tender fluctuant inguinal lymph nodes or characteristic proctogenital lesions with supportive laboratory findings of a single C. trachomatis complement fixation (CF) titer of greater than 64

Confirmed: a case that is laboratory confirmed

See also:

Printable Version

 


 



Privacy Policy | Accessibility

DISSS Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last updated January 9, 2008

United States Department of Health and Human Services
Centers for Disease Control and Prevention

"Epi Info" is a trademark of the Centers for Disease Control and Prevention (CDC).